Approval · Notice of Compliance 19151 · 2017
ENBREL: Notice of Compliance 19151
Issued April 12, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 19151
- Date
- April 12, 2017
- Company
- Immunex CorporationThousand Oaks, California, United States
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Additional manufacturing facility
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ENBREL | Not yet assigned | — |
Medicinal ingredients
- ETANERCEPT 25 MG per 0.5ML
- ETANERCEPT 50 MG per ML